Generic list of "Immunosuppressant"
Adalimumab
Adalimumab is a tumor necrosis factor (TNF) blocker indicated for treatment of:
Rheumatoid Arthritis (RA): Reducing signs and symptoms, inducing major clinical response, inhibiting the progression ...
Baricitinib
Baricitinib is indicated for the treatment of adult patients with moderate to severely active Rheumatoid Arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist ...
Cyclosporine (Oral)
Transplantation indications-
Solid organ transplantation
Bone marrow transplantation
Non-transplantation indications-
Endogenous uveitis
Nephrotic syndrome
Rheumatoid arthritis
Psoriasis
Atopic dermatitis
Etanercept
Adults with Rheumatoid Arthritis (RA): Etanercept indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function ...
Everolimus
Everolimus is indicated in advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer (Advanced HR+ BC), Advanced Neuroendocrine Tumors (NET); Advanced Renal Cell Carcinoma (RCC); Renal Angiomyolipoma ...
Imiquimod
Imiquimod cream is indicated for the topical treatment of-
External genital and perianal warts in adults.
Small superficial basal cell carcinomas in adults.
Clinically typical, nonhyperkeratotic ...
Methotrexate
Neoplastic Diseases:
Treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole
In acute lymphoblastic leukemia
Used in combination with other chemotherapeutic agents ...
Mycophenolate Mofetil
Mycophenolate Mofetil in combination with corticosteroids and either ciclosporin or tacrolimus is indicated for-
Prophylaxis of acute organ rejection and treatment of first or refractory organ rejection ...
Mycophenolic acid
Prophylaxis of organ rejection in kidney transplant: Mycophenolic acid is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant. It is indicated for the prophylaxis ...
Nivolumab
Nivolumab is a programmed death receptor-1 (PD-1)-blocking antibody indicated for the treatment of: Melanoma:
patients with unresectable or metastatic melanoma, as a single agent or in combination ...
Pembrolizumab
Pembrolizumab is a programmed death receptor-1 (PD-1)-blocking antibody indicated: Melanoma:
for the treatment of patients with unresectable or metastatic melanoma.
for the adjuvant treatment of ...
Pirfenidone
Pirfenidone is indicated in adults for the treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF).
Thalidomide
Multiple Myeloma: Thalidomide in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM). Erythema Nodosum Leprosum: Thalidomide is indicated ...
Tofacitinib
Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate ...